Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
NCT ID: NCT04892706
Description: None
Frequency Threshold: 5
Time Frame: 12 weeks
Study: NCT04892706
Study Brief: Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
IDP-126 Gel IDP-126 Gel: Gel applied to face once daily in the evening. 0 None 1 230 23 230 View
IDP-126 Vehicle Gel IDP-126 Vehicle Gel: Gel applied to face once daily in the evening. 0 None 0 228 0 228 View
Epiduo® Forte Gel Epiduo® Forte Gel: Gel applied to face once daily in the evening. 0 None 0 226 16 226 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Motor Vehicle Accident NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 24.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Application Site Pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA 24.0 View